Testing
Sequence alterations of the EGFR gene have frequently been identified in non-small cell lung carcinoma (NSCLC), primarily in those patients who were responsive to Gefitinib, an EGFR tyrosine kinase inhibitor.…
Learn more
Learn more
E3 ubiquitin-protein ligase, technical only
Learn more
Learn more
M EGFR
This sequencing panel is useful in determining eligibility for tyrosine kinase inhibitor (TKI) therapy in patients with non-small cell lung cancer (NSCLC). The EGFR mutation is present in 10-15% of… EGFR Mutation Analysis
Learn more
NSCLC,Cisplatin resistant cells; by IHC
Learn more
Learn more
An interstitial deletion of chromosome 5, del(5q), is associated with MDS/MPD and AML. Involvement of chromosome 5 is found in 40% of therapy-related myeloid disorders, whereas it is found in…
Learn more
Learn more
